AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Key Fund Holdings / Genzyme General was a top new buy of Alger MidCap Growth Fund as of the latest reporting period. The stock has been in a basing pattern since peaking at 103.75 on Dec. 8. Since troughing at 68.69, it's worked its way back above its 50-day moving average and is 15% under its old high. Earnings rose 22% and 18% the past two quarters. ...